C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute

Lavinia Forte1, Giovanni Cimmino, Francesco Loffredo

  • 1Department of Cardio-Thoracic and Respiratory Sciences, Second University of Naples, Italy.

Insights

C-reactive protein (CRP) is produced in coronary lesions and released into circulation in acute coronary syndromes (ACS), impairing endothelial function and linking CRP to ACS pathophysiology.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Atherosclerosis Studies

Background:

  • C-reactive protein (CRP) plasma levels are linked to cardiovascular events.
  • The role of CRP in acute coronary syndromes (ACS) pathophysiology is not well understood.
  • Investigating CRP production and its impact on coronary circulation in ACS is crucial.

Purpose of the Study:

  • To determine if CRP is produced in culprit lesions and released in the coronary circulation of ACS patients.
  • To assess the effect of CRP on coronary endothelial function in ACS.
  • To explore the relationship between CRP and ACS pathophysiology.

Main Methods:

  • Simultaneous blood sampling from aorta (Ao) and coronary sinus (CS) in patients with normal coronary artery, stable angina, and ACS.
  • Measurement of plasma CRP levels.
  • Evaluation of coronary vasodilation using Doppler Flow Wire in response to acetylcholine and adenosine.
  • Analysis of CRP mRNA in coronary plaques via quantitative PCR.

Main Results:

  • Significantly higher CRP levels across coronary circulation were observed only in ACS patients with left coronary artery culprit lesions.
  • No significant differences in CRP levels between CS and Ao in other patient groups.
  • Transcardiac CRP levels correlated with impaired endothelium-dependent vasodilation.
  • CRP mRNA was detected exclusively in unstable plaques from ACS patients.

Conclusions:

  • CRP is produced and released within the coronary circulation of ACS patients.
  • This release is associated with impaired endothelial function.
  • Suggests a novel pathophysiological link between CRP and ACS.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...